Thanks for the mention D CEO Magazine (Healthcare Business)
Update: There has been a price increase to $1000 to cover the true cost of infusion.
The Growth of Monoclonal Antibodies in North Texas
The treatment is being used to save those with COVID-19, but it shouldn’t replace the vaccine.
BY WILL MADDOX
PUBLISHED IN HEALTHCARE BUSINESS
AUGUST 30, 2021 3:00 PM
Monoclonal antibodies are being used more and more as COVID-19 hospitalizations are going up in North Texas. Though the treatment is not a replacement for the vaccine, it is being used to treat high-risk COVID-19 patients and prevent disease for those who have been exposed. The therapy has also proven to be effective against the delta variant, which is currently filling up hospitals and ICUs in North Texas and around the country.
Both Governor Greg Abbott and former President Donald Trump received Regeneron’s monoclonal antibody treatments when they caught COVID-19. Clinical trials showed that the treatment reduced hospitalization by 70 percent in high-risk patients. When given to someone who has been exposed, such as living with an infected person, monoclonal antibodies mitigate the risk of developing an infection by 80 percent. They function like the antibodies one produces from infection, only they are made in a lab. They bond with the proteins of the virus and block it from entering the body’s cells.
Like our LinkedIn page to get CourMed updates!
